Name | Value | Comments | |
---|---|---|---|
caseSensitive | true | ||
compositional | false | ||
content | complete | ||
copyright | This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html | ||
date | 2019-12-01 | ||
description | HL7-defined code system of concepts used to record event observations regarding what may have caused a product related event. Used in HL7 Version 2.x messaging in the PCR segment. | ||
experimental | false | ||
hierarchyMeaning | is-a | ||
jurisdiction | |||
name | CausalityObservations | ||
publisher | Health Level Seven International | ||
purpose | Underlying Master Code System for V2 table 0252 (Causality Observations) | ||
status | active | ||
title | causalityObservations | ||
url | http://terminology.hl7.org/CodeSystem/v2-0252 | ||
version | 2.0.0 | ||
versionNeeded | false |
Code | Display | status | deprecated | status | deprecated | Comments | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
AW | Abatement of event after product withdrawn | A | A | A | A | ||||||
BE | Event recurred after product reintroduced | A | A | A | A | ||||||
LI | Literature reports association of product with event | A | A | A | A | ||||||
IN | Event occurred after product introduced | A | A | A | A | ||||||
EX | Alternative explanations for the event available | A | A | A | A | ||||||
PL | Effect observed when patient receives placebo | A | A | A | A | ||||||
TC | Toxic levels of product documented in blood or body fluids | A | A | A | A | ||||||
DR | Dose response observed | A | A | A | A | ||||||
SE | Similar events in past for this patient | A | A | A | A | ||||||
OE | Occurrence of event was confirmed by objective evidence | A | A | A | A | ||||||
OT | Other | A | A | A | A |